INR 4.41
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.6 Million INR | -40.31% |
2022 | 7.86 Million INR | 210.58% |
2021 | 2.53 Million INR | 1025.33% |
2020 | 225 Thousand INR | -83.68% |
2019 | 1.37 Million INR | 49.24% |
2018 | 924 Thousand INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 703 Thousand INR | 0.0% |
2023 Q1 | 168.99 Thousand INR | -96.66% |
2023 Q4 | 1.75 Million INR | 106.96% |
2023 Q2 | 2.94 Million INR | 1639.66% |
2023 FY | 4.69 Million INR | -40.31% |
2023 Q3 | 847.49 Thousand INR | -71.17% |
2022 Q3 | 3.76 Million INR | 196.46% |
2022 Q2 | 1.27 Million INR | 0.0% |
2022 FY | 7.86 Million INR | 210.58% |
2022 Q1 | 1.27 Million INR | -51.72% |
2022 Q4 | 5.06 Million INR | 34.58% |
2021 Q1 | 2.29 Million INR | 0.0% |
2021 FY | 2.53 Million INR | 1025.33% |
2021 Q4 | 2.63 Million INR | 73.12% |
2021 Q3 | 1.51 Million INR | -67.95% |
2021 Q2 | 4.74 Million INR | 106.3% |
2020 FY | 225 Thousand INR | -83.68% |
2019 FY | 1.37 Million INR | 49.24% |
2018 FY | 924 Thousand INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Ajanta Pharma Limited | 30.46 Billion INR | 99.995% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 99.854% |
Sigachi Industries Limited | 579.88 Million INR | 99.723% |
Bal Pharma Limited | 389.89 Million INR | 99.587% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 99.924% |
Medico Remedies Limited | 161.84 Million INR | 99.006% |
Lasa Supergenerics Limited | 291.17 Million INR | 99.447% |
Venus Remedies Limited | 1.91 Billion INR | 99.916% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 99.948% |
Alpa Laboratories Limited | 156.14 Million INR | 98.97% |
Nectar Lifesciences Limited | 625.55 Million INR | 99.743% |
Shilpa Medicare Limited | 2.18 Billion INR | 99.926% |
Aarti Drugs Limited | 1.16 Billion INR | 99.862% |
Lupin Limited | 95.67 Billion INR | 99.998% |
Aurobindo Pharma Limited | 39.23 Billion INR | 99.996% |
Zydus Lifesciences Limited | 43.17 Billion INR | 99.996% |
Windlas Biotech Limited | 1 Billion INR | 99.84% |
Suven Life Sciences Limited | 109.75 Million INR | 98.534% |
Eris Lifesciences Limited | 4.94 Billion INR | 99.967% |
Valiant Laboratories Limited | 36.28 Million INR | 95.566% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 99.981% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 99.965% |
Ipca Laboratories Limited | 13.91 Billion INR | 99.988% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 99.887% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.999% |
Bajaj HealthCare Limited | 985.34 Million INR | 99.837% |
RPG Life Sciences Limited | 1.63 Billion INR | 99.902% |
Mankind Pharma Limited | 23.15 Billion INR | 99.993% |
Laurus Labs Limited | 3.01 Billion INR | 99.947% |
Piramal Pharma Limited | 19.91 Billion INR | 99.992% |
Syncom Formulations (India) Limited | 942.39 Million INR | 99.829% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 99.992% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 99.99% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 99.998% |
Unichem Laboratories Limited | 6.72 Billion INR | 99.976% |
Sequent Scientific Limited | 2.9 Billion INR | 99.945% |
Novartis India Limited | 470.1 Million INR | 99.658% |
Wanbury Limited | 1.16 Billion INR | 99.861% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 99.885% |
Wockhardt Limited | 6.4 Billion INR | 99.975% |
Themis Medicare Limited | 782.85 Million INR | 99.794% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | 99.792% |
Jubilant Pharmova Limited | 14.45 Billion INR | 99.989% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 99.986% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.998% |
Divi's Laboratories Limited | 14.17 Billion INR | 99.989% |
NATCO Pharma Limited | 10.05 Billion INR | 99.984% |
Gufic Biosciences Limited | 1.07 Billion INR | 99.851% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 99.854% |
Ind-Swift Limited | 946.56 Million INR | 99.83% |
Procter & Gamble Health Limited | 2.99 Billion INR | 99.946% |
FDC Limited | 5.34 Billion INR | 99.97% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | 96.514% |
Granules India Limited | 7.18 Billion INR | 99.978% |
Medicamen Biotech Limited | 335.16 Million INR | 99.52% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.995% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 99.938% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | 90.074% |
Brooks Laboratories Limited | 51.18 Million INR | 96.856% |
Megasoft Limited | 49.52 Million INR | 96.751% |
ZIM Laboratories Limited | 1.01 Billion INR | 99.841% |
Strides Pharma Science Limited | 9.16 Billion INR | 99.982% |
Neuland Laboratories Limited | 2.92 Billion INR | 99.945% |
Morepen Laboratories Limited | 1.98 Billion INR | 99.919% |
Hikal Limited | 2.48 Billion INR | 99.935% |
Indoco Remedies Limited | 4.74 Billion INR | 99.966% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 99.948% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 99.61% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | 99.762% |
Hester Biosciences Limited | 908.84 Million INR | 99.823% |